In this month’s trial, which began on Aug. 28, Eric Olson ( Olson Grimsley) and Ashley Keller ( Keller Postman) represented ...

The FDA banned sales of ranitidine in 2020 over possible contamination with the suspected carcinogen N-nitrosodimethylamine (NDMA. Some manufacturers of the drug voluntarily suspended sales in ...

Recent surprise decisions have upended plaintiffs’ expectations on the toxic tort front. In Delaware, the top court is ...

Hung jury in latest Zantac cancer trial in Chicago Boehringer Ingelheim only defendant after settlements with GSK, Pfizer FDA pulled Zantac in 2020 over NDMA carcinogen concerns Sept 18 (Reuters ...

A Chicago jury failed to reach a verdict Sept. 18 over claims that heartburn drug Zantac causes cancer, Reuters exclusively reported. The case, brought by Illinois resident Ronald Kimbrow ...

This summary presents key updates in the health sector. Highlights include UnitedHealth's tech unit customers adopting ...

Twelve days after GSK secured a key win in Florida, with a state court tossing expert testimony on the cancer-causing potential of heartburn drug Zantac (ranitidine), the British company has ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

This health news summary covers significant topics including UnitedHealth tech unit's post-hack customer situation, new ...

The companies, which also include Pfizer and Sanofi, are challenging a lower court ruling that allowed expert testimony claiming Zantac causes cancer – a link they say is not credible.

On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer Boehringer Ingelheim, the second in the past two months. Another jury in the ...

GSK plc (LSE/NYSE: GSK), a leading global pharmaceutical company, has reached a confidential settlement in a Zantac (ranitidine) related prostate cancer lawsuit filed by Mr. Isaac Dixon in ...